Keywords: اول در انسان; Biotherapeutics; Gene and cell therapy; Pharmacokinetics; Non-clinical safety; Immunogenicity; Cross-reactive species; ATMP; advanced therapy medicinal products; CAR; chimeric antigen receptor; CD; cluster of differentiation; CMC; chemistry manufacturing
مقالات ISI اول در انسان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اول در انسان; Extemporaneous preparation; Oral solution; Hydroxypropylbetadex; Stability; Compatibility; Taste masking; First-in-human; Early phase development; Pharmacokinetics;
Keywords: اول در انسان; catheter ablation; electrogram; first-in-human; histology; remapping; AF; atrial fibrillation; CF; contact force; DT; DiamondTemp; EGM; electrogram; PV; pulmonary vein; RF; radiofrequency;
Keywords: اول در انسان; TESM; tissue engineered skeletal muscle; BAP; bioartificial pancreas; TM; therapeutic misconception; TD; translational distance; FIH; first-in-human; CRO; contract research organization; Human research ethics; Animal research ethics; Translational researc
Keywords: اول در انسان; CFR; Code of Federal Regulations; COI; conflict of interest; FIH; first-in-human; GCP; good clinical practice; ICF; informed consent form; ICH; International Conference on Harmonization; IRB; institutional review board; TM; therapeutic misconception; TMis
Keywords: اول در انسان; Adverse events; Central nervous system; First-in-human; Functional observational battery; Methods; Neurobehavioural assessment; Predictive value; Translation;
Keywords: اول در انسان; coronary bifurcation; double-stent technique; first-in-human; in vitro; percutaneous interventionGW, guidewire; MB, main branch; mCT, micro computed tomography; OCT, optical coherence tomography; PCI, percutaneous coronary intervention; QCA, quantitative
Keywords: اول در انسان; ADC; antibody-drug conjugate; ADME; absorption, distribution, metabolism and elimination; EFD; embryofetal development; ELISA; enzyme-linked immunosorbent assay; FIH; first-in-human; GLP; Good Laboratory Practice; hERG; human ether-Ã -go-go related gene;
A validated UPLC-MS/MS method for the quantitation of an unstable peptide, monocyte locomotion inhibitory factor (MLIF) in human plasma and its application to a pharmacokinetic study
Keywords: اول در انسان; MLIF; Ischemic stroke; UPLC-MS/MS; Pharmacokinetics; First-in-human;
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
Keywords: اول در انسان; CD3 bispecific; MABEL; First-in-human dose; Oncology drug development; FIH; first-in-human; CRA; cytokine release assay; CRS; cytokine release syndrome; GLP; good laboratory practice; HHD; highest human dose; HNSTD; highest non-severely toxic dose; IB; In
An FDA oncology analysis of immune activating products and first-in-human dose selection
Keywords: اول در انسان; MABEL; Immune oncology; First-in-human dose; ADCC; antibody-dependent cellular cytotoxicity; CRA; cytokine release assay; CRS; cytokine release syndrome; DLT; dose limiting toxicity; EMA; European Medicines Agency; FIH; first-in-human; HHD; highest human
Quantitative prediction of human pharmacokinetics and pharmacodynamics of imigliptin, a novel DPP-4 inhibitor, using allometric scaling, IVIVE and PK/PD modeling methods
Keywords: اول در انسان; Imigliptin; Pharmacokinetics; Pharmacodynamics; Prediction; First-in-human
Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System : First-in-Human Experience
Keywords: اول در انسان; adventitial; alcohol; chemical; ethanol; first-in-human; neurolysis; renal denervation; sympathetic nervesBP, blood pressure; eGFR, estimated glomerular filtration rate; OBP, office-based blood pressure; RF, radiofrequency
Clinical Characterization of Coronary Atherosclerosis With Dual-Modality OCT and Near-Infrared Autofluorescence Imaging
Keywords: اول در انسان; first-in-human; multimodality imaging; near-infrared fluorescence; optical coherence tomography; DCF; double-clad fiber; LAD; left anterior descending coronary artery; LCx; left circumflex coronary artery; NIRAF; near-infrared autofluorescence; NIRS; ne
An FDA oncology analysis of antibody-drug conjugates
Keywords: اول در انسان; AD; acceptable dose; ADC; antibody-drug conjugate; ADCC; antibody-dependent cellular cytotoxicity; FIH; first-in-human; HNSTD; highest non-severely toxic dose; ICH; International Conference on Harmonization; LC/MS; liquid chromatography/mass spectrometry;
First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers
Keywords: اول در انسان; Genetically attenuated parasite; First-in-human; Malaria; Plasmodium falciparum;
NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults
Keywords: اول در انسان; Vaccine; Phase 1; First-in-human; Als3p; Candida; Staphylococcus aureus;
Comparative requirements for exploratory clinical trials — eIND, eCTA and microdosing
Keywords: اول در انسان; Safety assessment; Exploratory; Clinical trial; Microdosing; eIND; eCTA; Toxicology; Toxicity study; First-in-human; Translational medicine
PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 1: Goals, Properties of the Phrma Dataset, and Comparison with Literature Datasets
Keywords: اول در انسان; allometry; bioavailability; clearance; computational ADME; first-in-human; pharmacokinetics; oral absorption; PhRMA; PBPK; volume of distribution;